Inventor
Harald Holte
Inventor
Oslo, NO
Overview
Patents· 4 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
C12Qprimary
C12QMeasuring or testing processes involving enzymes, nucleic acids or microorganisms29%
G01NInvestigating or analysing materials by determining their chemical or physical properties29%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations14%
G16BBioinformatics, i.e. information and communication technology [ict] specially adapted for genetic or protein-related data processing in computational molecular biology14%
Y02ATechnologies for adaptation to climate change14%
PatentTitleYear
11,028,444Survival predictor for diffuse large B cell lymphoma202110,697,975Methods for identifying, diagnosing, and predicting survival of lymphomas20209,970,059Survival predictor for diffuse large B cell lymphoma20188,131,475'Methods for identifying, diagnosing, and predicting survival of lymphomas'2012Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2012–2021Patents assigned to UNIV BARCELONA (4)· patent assignee history
2012–2021Patents assigned to UNIV NEBRASKA (4)· patent assignee history
2012–2021Patents assigned to UNIV ROCHESTER (4)· patent assignee history
2012–2021Patents assigned to US HEALTH (4)· patent assignee history
2012–2021Based in Oslo, NO· patent location history
2018–2021Patents assigned to BRITISH COLUMBIA CANCER AGENCY BRANCH (3)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| UNIV BARCELONA | 4 | 2012–2021 |
| UNIV NEBRASKA | 4 | 2012–2021 |
| UNIV ROCHESTER | 4 | 2012–2021 |
| US HEALTH | 4 | 2012–2021 |
| BRITISH COLUMBIA CANCER AGENCY BRANCH | 3 | 2018–2021 |
Locations
| Location | Patents | Span |
|---|---|---|
| Oslo, NO | 4 | 2012–2021 |